InkVivo is developing a bioresorbable implant that will increase the therapeutic efficacy (e.g. postoperative pain) while reducing perioperative interventions, thus, it will provide an earlier patient discharge with faster rehabilitation. We leverage our patented biomaterial platform to fabricate implants with the ability to release drugs in a controlled spatiotemporal manner while boosting tissue healing. With our technology we intend to enter the rapidly growing 3D-printed drugs market.